申请人:NHWA Pharma Corporation
公开号:EP3381915A1
公开(公告)日:2018-10-03
The present invention relates to a lactam compound derivative, a medicine composition comprising the lactam compound derivative, and uses of the composition and the lactam compound derivative in preparation of a medicine for preventing or treating schizophrenia, the lactam compound derivative having a structure as shown in Formula I.
本发明涉及一种内酰胺化合物衍生物、一种包含该内酰胺化合物衍生物的药物组合物,以及该组合物和内酰胺化合物衍生物在制备预防或治疗精神分裂症的药物中的用途,该内酰胺化合物衍生物具有如式 I 所示的结构。